As a company with close partnerships within medical centers and hospitals, GenomeScan is aware that reliable access to your sequencing data can be of crucial importance to your patients or your study. Thanks to our online platforms and Bio-IT infrastructure, our ongoing projects with laboratories in life science, healthcare and pharmaceutical industries proceed without interruption, despite the challenges many service…
Project management via digital platforms The coronavirus outbreak is impacting the way we live, changing the way we work and transforming the way we communicate with each other. We know that the spread of COVID-19 does not remove the need to access high-quality scientific support and advice. Many laboratories in life science, healthcare and pharmaceutical industries are being affected by…
“In these unique circumstances, our team is dedicating its time, expertise and talents to support the healthcare and scientific communities and their scientific programs.” GenomeScan has a crucial function and stays operational GenomeScan fully understands the measures announced recently by the Dutch government and is stepping up to the challenge ahead. Kees van den Berg, CEO of GenomeScan summarizes…
The new coronavirus presents one of the most serious challenges we have ever faced. Laboratories are expected to provide consistent performance. Due to the COVID-19 outbreak and related uncertainties, it is quite a challenge to perform laboratory tests at the usual quality level. Quality and compliance at GenomeScan At GenomeScan, it is the task of the QA Department to make…
The current coronavirus situation is new and quite challenging for all of us. In this moment, at GenomeScan, we are committed to keeping our employees, customers and suppliers safe while still offering the best possible service. Visitor’s notice Under normal circumstances access to GenomeScan’s laboratory is limited to authorized individuals in order to safeguard laboratories and secure important research equipments…
GenomeScan’s activities during this unprecedent Coronavirus crisis GenomeScan is first and foremost concerned with the health of its staff, community and the larger public. The current coronavirus situation is new and quite challenging for all of us. In this moment, at GenomeScan, we are committed to keeping our employees, customers and suppliers safe, while still offering the best possible service….
FASTER, BETTER, AFFORDABLE. BiotechNEWS has recently interviewed our CEO, Kees van den Berg. According to Kees, the future of diagnostics is all about personalized medicine. In this article (in Dutch), he describes the expansion of GenomeScan and the relationship with LUMC and ErasmusMC. He also highlights the current trends in NGS and comments on future developments in healthcare. Enjoy… Published…
Improvements in Gene Panel and Whole Exome sequencing Molecular barcoding refers to the attachment of a unique molecular sequence (eg. ATGCCA) to each individual DNA fragment in a sample. This ensures that in downstream analysis, unique sequence reads can be separated from those originating as a result of PCR duplication. A common practice regarding these PCR duplicates is to search…
Transcription profiles give accurate images of the biological processes that influence cell fates. However, library construction can introduce bias at multiple steps. For example, PCR amplification increases the number of cDNA molecules to an amount sufficient for sequencing, but also stochastically introduces errors and amplifies different molecules with unequal probabilities. The sequencing reads that have been created from the same…
If you start analyzing your gene-expression data set, many questions come to mind that can seriously affect the outcome. What if any of the PCR steps during library prep (Figure 1) has introduced an error? It might have led to a base change, which I could incorrectly score as a mutation. Did a PCR-bias favor amplification of some of the…
Recent Comments